Division 8.1.5 Endocrine disrupting properties
United Kingdom
Consideration shall be given to whether the active substance is a potential endocrine disruptor according to F1national or internationally agreed guidelines. This may be done in consulting the mammalian toxicology section (see Section 5). In addition, other available information on toxicity profile and mode of action shall be taken into account. If as a result of this assessment, the active substance is identified as a potential endocrine disruptor, the type and conditions of the study to be performed shall be discussed with the F2... competent authorities.
Annotations
Textual amendments
- F1
Word in Annex Pt. A point 8.1.5 substituted (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), regs. 1(1), 21(5)(b)(xv)(aa); 2020 c. 1, Sch. 5 para. 1(1)
- F2
Word in Annex Pt. A point 8.1.5 omitted (31.12.2020) by virtue of The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), regs. 1(1), 21(5)(b)(xv)(bb); 2020 c. 1, Sch. 5 para. 1(1)